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ARTICLE
Locking loop movement in the ubiquinone pocket
of complex I disengages the proton pumps
Alfredo Cabrera-Oreﬁce1,2, Etienne Galemou Yoga3,4, Christophe Wirth 5, Karin Siegmund3,4,
Klaus Zwicker 6, Sergio Guerrero-Castillo1, Volker Zickermann 2,3,4, Carola Hunte 5 & Ulrich Brandt 1,2
Complex I (proton-pumping NADH:ubiquinone oxidoreductase) is the largest enzyme of the
mitochondrial respiratory chain and a signiﬁcant source of reactive oxygen species (ROS).
We hypothesized that during energy conversion by complex I, electron transfer onto ubi-
quinone triggers the concerted rearrangement of three protein loops of subunits ND1, ND3,
and 49-kDa thereby generating the power-stoke driving proton pumping. Here we show that
ﬁxing loop TMH1-2ND3 to the nearby subunit PSST via a disulﬁde bridge introduced by site-
directed mutagenesis reversibly disengages proton pumping without impairing ubiquinone
reduction, inhibitor binding or the Active/Deactive transition. The X-ray structure of mutant
complex I indicates that the disulﬁde bridge immobilizes but does not displace the tip of loop
TMH1-2ND3. We conclude that movement of loop TMH1-2ND3 located at the ubiquinone-
binding pocket is required to drive proton pumping corroborating one of the central pre-
dictions of our model for the mechanism of energy conversion by complex I proposed earlier.
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Respiratory complex I feeds redox equivalents into oxidativephosphorylation. By linking electron transfer from NADHto ubiquinone with the translocation of four protons across
the inner mitochondrial membrane, it generates a major portion
of the proton motive force driving aerobic ATP synthesis and the
transport of metabolites. Complex I is also a key player in sig-
naling and pathologic mechanisms associated with reactive oxy-
gen species (ROS) in humans1. Yet, the molecular mechanism
and regulation of energy conversion and ROS production by
complex I remain poorly understood. Recent structures of com-
plex I from different species obtained by X-ray crystallography2,3
and cryo-electron microscopy4–7 showed that FMN and a chain
of seven iron–sulfur clusters reside in its peripheral arm (N/Q
modules) and connect the NADH oxidation site to the ubiqui-
none reduction site. As had been proposed earlier8,9, the latter is
located signiﬁcantly above the membrane surface and remote
from the four putative pump sites distributed over the long
membrane arm (P module) of complex I2 (Supplementary
Fig. 1a). It has been proposed that energy transmission between
the pump sites occurs via electrostatic and conformational
transmission along an axis of protonable residues at the center of
the membrane arm10 and this concept is supported by recent
molecular modeling studies11,12. It is still a matter of debate, how
the energy released during ubiquinone reduction is converted into
the power stroke sent along the P-module to drive the proton
pumps of complex I.
If substrates are added to complex I from vertebrates and fungi
that has been idling for some time at physiological temperatures,
activity is very low initially, but then returns to maximal
levels13,14. The physiological role of this so called Active/Deactive
(A/D) transition of mitochondrial complex I remains unclear, but
locking the enzyme in the D-form prevents cardiac reperfusion
injury in vivo15. Interconversion from D-form to A-form can be
blocked by divalent cations (Me2+), alkaline pH or by any kind of
covalent modiﬁcation of a single cysteine residue16 that is only
accessible in the D-form17. This cysteine resides in the hydro-
philic TMH1-2 loop of the mitochondrially-encoded subunit
ND318 putatively involved in catalysis2 and is thus also ideally
positioned to control the A/D transition of complex I.
Based on insights from the X-ray structure of Yarrowia lipo-
lytica complex I, we hypothesized2 that during turnover nega-
tively charged ubiquinone intermediates trigger the concerted
movement of three protein loops to generate the power stroke
driving the proton pumps, in line with the principles of the earlier
proposed two-state stabilization change mechanism19 (Supple-
mentary Fig. 1b). These loops are (a) the β1–β2 loop of 49-kDa
subunit involved in binding the ubiquinone headgroup; (b) the
TMH1-2 loop of subunit ND3 and (c) the highly acidic TMH5-6
loop of subunit ND1. In the cryo-EM4–7 structures of mammalian
complex I3,4 these loops exhibited pronounced structural ﬂex-
ibility lending support to our mechanistic hypothesis2. In fact, in
the recently obtained cryo-EM structures of the deactive enzyme
several domains near the ubiquinone-binding pocket were dis-
ordered, which included major parts of the respective loops in the
49-kDa and ND3 subunits5,6. In contrast, in the X-ray structure
of the deactive form of Y. lipolytica complex I the corresponding
loops showed continuous density except for loop TMH1-2ND3,
for which only the protein backbone of the stretch in immediate
contact with the ubiquinone-binding pocket could be modelled2.
The varying degree by which these loops are disordered in the
deactive form of the enzyme may reﬂect the differences in the
stability and energetics of the A/D conversion between mam-
malian and fungal complex I reported earlier14. Moreover,
molecular modeling studies point toward functional importance
of structural rearrangements involving the same loop
domains11,12.
Here we show that blocking the movement of loop TMH1-
2ND3 by tethering it to subunit PSST by an engineered disulﬁde
bridge reversibly disengages the proton pumps of mitochondrial
complex I, without affecting kinetic parameters of ubiquinone
reduction, A/D transition or proton permeability of the mem-
brane domain. We conclude that movement of loop TMH1-2ND3
is required to drive the proton pumps of complex I.
Results
Introducing a disulﬁde bridge to ﬁx loop TMH1-2ND3. We
reasoned that, if movement of the three loops lining the
ubiquinone-binding cavity was indeed required for the mechan-
ism and regulation of mitochondrial complex I, locking one of
them should interfere with ubiquinone reduction, proton
pumping and/or A/D transition. To ﬁx loop TMH1-2ND3 by
introducing an artiﬁcial disulﬁde bridge, we took advantage of the
available structures of complex I and identiﬁed suitable positions
in subunits PSST and 49-kDa for introducing a second cysteine
near C40 of loop TMH1-2ND3. Making use of the genetic
accessibility of the yeast Y. lipolytica, we replaced Q133 in subunit
PSST (NUKM in Y. lipolytica) by a cysteine using site-directed
mutagenesis. When we treated complex I puriﬁed from strain
Q133CPSST with Ellman’s reagent (5,5′-dithiobis-2-nitrobenzoic
acid; DTNB)20, which promotes the formation of disulﬁde
bridges from adjacent cysteine-thiols, an additional band occur-
red in non-reducing SDS-PAGE migrating between subunits ND1
and 30-kDa (Fig. 1a). The band was not observed in complex I
from the parental strain or after reduction with dithiothreitol
(DTT). The presence of a disulﬁde cross-link between subunits
ND3 and PSST was conﬁrmed by LC-ESI tandem mass spec-
trometry (MS) (Fig. 1b) and also by separating the two proteins in
a second dimension SDS-PAGE at reducing conditions (Fig. 1c).
Furthermore, non-crosslinked subunits PSST and ND3 were
hardly detectable by MS in DTNB-treated complex I from strain
Q133CPSST (Supplementary Fig. 2) demonstrating almost com-
plete formation of the inter-subunit disulﬁde bridge.
No effect of Q133CPSST on assembly and enzyme kinetics.
Blue-native (BN) PAGE of mitochondrial membranes from strain
Q133CPSST revealed that assembly and content of complex I were
not affected by the mutation (Supplementary Fig. 3a). Conﬁrming
normal content of complex I and indicating a fully functional
NADH oxidation site, deamino-NADH:hexaammineruthenium
(dNADH:HAR) oxidoreductase activity was unchanged (Sup-
plementary Fig. 3b) and inhibitor-sensitive dNADH:decylubi-
quinone (dNADH:DBQ) oxidoreductase appeared only 10–15%
lower barely reaching statistical signiﬁcance (Table 1; Supple-
mentary Fig. 3c). With puriﬁed complex I, treatment with DTNB
reduced all activities by ~10%, and this minor effect did not
correlate with cross-link formation in mutant Q133CPSST
(Tables 1, 2). Moreover, the minimal effect on maximal turnover
also excluded signiﬁcant interference by stable modiﬁcations of
the cysteines by the reagent under the conditions used. Major
inactivation of complex I was however observed, when much
longer incubation times (>15 min) than those applied in the
experiments described here (5 min) were applied. No signiﬁcant
differences in Vmax and KM values for decylubiquinone were
observed between parental and mutant complex I (Table 1,
Supplementary Fig. 4a, b). The sensitivities to the speciﬁc com-
plex I inhibitors n-decyl-quinazoline-amine (DQA) and rotenone
were the same in parental and mutant complex I (Table 1; Sup-
plementary Fig. 4c-f). No effects of mutation Q133CPSST on the
immediate electron donor for ubiquinone, iron–sulfur cluster N2,
and other iron–sulfur clusters were detected by continuous-wave
electron paramagnetic resonance (cw-EPR) spectroscopy of
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06955-y
2 NATURE COMMUNICATIONS |          (2018) 9:4500 | DOI: 10.1038/s41467-018-06955-y | www.nature.com/naturecommunications
puriﬁed complex I (Supplementary Fig. 5). Treatment with DTT
and DTNB had some minor effects on the intensity and shape of
the EPR signatures, but these were the same with parental and
mutant enzyme. Taken together, functional analysis demon-
strated that mutation Q133CPSST had no detectable effect on
redox centers and the electron transfer activities within the per-
ipheral arm of complex I indicating that the structure of the
domains executing these functions were essentially unchanged.
No effect of Q133CPSST on A/D transition. To explore whether
the A/D transition was affected by blocking the movement of the
loop TMH1-2ND3 carrying the cysteine only accessible in the D-
form, we measured complex I activities in the presence of MgCl2
or N-ethylmaleimide (NEM), which react with the D-form only
and prevent its transition to the A-form in a reversible or irre-
versible fashion, respectively16. Note that different than the
mammalian enzyme16, Mg2+ locks complex I from Y. lipolytica
very efﬁciently and stably in the D-form making it a valid tool to
assay the D-form (Supplementary Fig. 6). Mg2+ prevented reac-
tivation of complex I from both parental and strain Q133CPSST to
very similar extents after DTT and DTNB treatment (Fig. 2a). In
mutant Q133CPSST treated with DTNB, NEM locked only a small
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Fig. 1 A disulﬁde cross-link is formed between subunits ND3 and PSST in mutant Q133CPSST. Puriﬁed complex I from parental and mutant strains were
incubated with either 5 mM dithiothreitol (DTT) or 0.1 mM 5,5′-dithiobis-2-nitrobenzoic acid (DTNB) for 5 min and then separated by non-reducing Tricine
SDS-PAGE. a An additional band was observed in the sample from mutant Q133CPSST treated with DTNB. b Mass spectrometric analysis of the
corresponding gel slice conﬁrmed the presence of cross-linked subunits PSST and ND3 and allowed label free quantiﬁcation of their relative abundance as
compared to the corresponding gel slice of the DTT treated sample (mean ± s.d.; n= 3 technical replicates; ***p < 0.001, ANOVA with Bonferroni
correction). c Subunits PSST and ND3 were also identiﬁed by dSDS-PAGE, in which the cross-link was preserved in the ﬁrst dimension (1D) and then
reduced in the second dimension (2D) to separate both proteins at a shifted position in the mutant. Note that the spot containing subunit PSST does not
disappear after cross-linking, because it also contains accessory subunits NUJM and NUPM37
Table 1 Functional characterization of complex I in mitochondrial membranes
Strain Treatmenta HAR activityb Vmaxc KMd IC50e
DQA Rotenone
µmol min-1 mg-1 µmol min-1 mg-1 µM nM nM
Parental – 0.860 ± 0.02 0.193 ± 0.02 n.d.f n.d. n.d.
DTT 0.842 ± 0.04 0.160 ± 0.02 17 ± 3 16 ± 3 560 ± 55
DTNB 0.726 ± 0.06 0.139 ± 0.07 20 ± 2 12 ± 2 524 ± 70
Q133CPSST – 0.834 ± 0.11 0.165 ± 0.01 n.d. n.d. n.d.
DTT 0.814 ± 0.06 0.143 ± 0.02 19 ± 3 13 ± 3 598 ± 65
DTNB 0.688 ± 0.04 0.136 ± 0.05 21 ± 3 17 ± 3 593 ± 82
aMitochondrial membranes were incubated with 5 mM DTT or 0.1 mM DTNB for 5 min before assay. Three independent batches of membranes were analyzed. Data are given as mean ± s.d.
bdNADH:HAR oxidoreductase activity
cTo account for variations in complex I content in different batches of mitochondrial membranes, dNADH:DBQ oxidoreductase activities were normalized to their speciﬁc HAR activities
dApparent KM for decylubiquinone (DBQ) was determined by ﬁxing the [dNADH] to 100 µM and varying the [DBQ] between 0 and 100 µM
eIC50 values were determined from curves shown in Supplementary Fig. 4. dNADH:DBQ oxidoreductase activities were measured in the presence of both substrates at 100 µM and varying the inhibitor
concentration
fNot determined
Table 2 Activities of puriﬁed complex I reconstituted into
proteoliposomes
Strain Treatmenta Complex I activityb Coupling ratioc
−CCCP +CCCP
µmol min-1 mg-1
Parental – 4.6 ± 1.1 12.5 ± 1.9 2.7
DTT 4.9 ± 1.4 13.1 ± 2.1 2.7
DTNB 4.5 ± 1.5 11.8 ± 2.4 2.6
Q133CPSST – 8.4 ± 0.8 9.7 ± 0.5 1.2
DTT 4.8 ± 1.0 10.4 ± 0.4 2.2
DTNB 8.1 ± 1.0 9.5 ± 0.4 1.1
aProteoliposomes were incubated with 5 mM DTT or 0.1 mM DTNB for 5 min before
oxidoreductase activity measurements. Three independent batches of proteoliposomes were
analyzed. Data are given as mean ± s.d.
bDQA-sensitive NADH:DBQ oxidoreductase activities were measured in the absence or
presence of 5 µM CCCP. To correct for variations in content and orientation of complex I in the
proteoliposomes, values were normalized to their respective NADH:HAR oxidoreductase
activities, which were 40 ± 1 µmol min-1 mg-1 and 35 ± 1 µmol min-1 mg-1 for parental and mutant
Q133CPSST samples, respectively
cCoupling ratios were calculated by dividing the NADH:DBQ oxidoreductase activities in the
presence of 5 µM CCCP by the activities in its absence
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fraction of complex I in the D-form (Fig. 2b). This was expected,
since under these conditions, the cysteine in loop TMH1-2ND3
was engaged in the cross-link with subunit PSST and thus was not
available to react with the thiol-agent. It follows that formation of
the disulﬁde bridge attaching loop THM1-2ND3 to subunit PSST
had no effect on the A/D transition. This is remarkable, since
covalently alkylating C40ND3 by NEM after breaking the disulﬁde
with DTT still locked complex I from mutant Q133CPSST in the
D-form.
Fixing loop THM1-2ND3 reversibly disengages the proton
pumps. To test whether the Q133CPSST mutation affected proton
pumping, we reconstituted puriﬁed complex I into proteolipo-
somes and measured pH gradient formation by monitoring the
quenching of 9-amino-6-chloro-2-methoxyacridine (ACMA).
After addition of DTT, mutant complex I was clearly able to
pump protons, although at somewhat reduced efﬁciency com-
pared to control (Fig. 3a, b). Assuming similar electron transfer
rates, this could be either due to a lower pumping stoichiometry
or due to slipping of the proton pumping machinery. In contrast,
when the disulﬁde crosslink was formed in the mutant complex I
by incubation with DTNB, pH gradient formation was abolished
almost completely, while it had no effect at all in the control
(Fig. 3c, d). This shows that blocking the movement of the ND3
loop speciﬁcally disengaged the proton pumps. Importantly, this
block was found to be fully reversible, since releasing the loop by
adding DTT during the assay restored proton pumping within
seconds (Fig. 3e, f). Declutching of the pumps by the inter-
subunit crosslink was further corroborated by the ﬁnding that the
activity of mutant complex I could be increased signiﬁcantly by
carbonylcyanide m-chlorophenylhydrazine (CCCP) only when
the disulﬁde bond was broken, while even in the absence of the
protonophore rates were already at uncoupled levels after DTNB
treatment (Table 2). Notably, untreated liposomes containing
complex I from mutant Q133CPSST were also largely uncoupled
suggesting the disulﬁde bridge in most of the enzyme had already
formed over time by air oxidation.
Disengaging the proton pumps does not cause a proton leak.
Roberts and Hirst21 reported that the deactive form exhibits
Na+/H+ antiporter activity for mammalian complex I, although
it should be noted that no indications for Na+ transport by
complex I were found for the Y. lipolytica enzyme22. Yet, it
seemed conceivable that disconnecting the proton pumps of
complex I from the ubiquinone reaction machinery could create a
proton leak in the P-module. To assess the proton leak, we fol-
lowed the decay of a proton gradient across the membrane of
complex I proteoliposomes created by the addition of an aliquot
of HCl and measured the formation of a proton gradient driven
by an electric membrane potential generated by applying a K+
gradient and adding the K+ speciﬁc ionophore valinomycin. As
shown in Fig. 4, the rate of the non-enzymatic proton leak was
identical for proteoliposomes containing complex I from the
parental strain and mutant Q133CPSST, both under oxidizing and
reducing conditions. We concluded that disengaging the proton
pumps by tethering loop TMH1-2ND3 to subunit PSST did not
increase the permeability of the P-module of complex I for
protons.
The disulﬁde bridge does not displace loop THM1-2ND3. To
understand the observed changes at the atomic level, we crys-
tallized complex I and determined the X-ray structure of variant
Q133CPSST under conditions favoring formation of the disulﬁde
bond (Supplementary Table 1). Taking advantage of the anom-
alous signal of sulfur atoms at 5.975 keV23,24, a strong peak in the
anomalous Fourier electron density map indeed indicated pre-
sence and location of a disulﬁde bond (Fig. 5, Supplementary
Table 1). The structure was reﬁned at an anisotropic resolution of
4.2 × 4.2 × 3.8 Å. It is overall very similar to the previously
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Fig. 2 Fixing loop TMH1-2ND3 does not interfere with complex I activity and
A/D transition. Mitochondrial membranes from parental and mutant
strains were incubated with 5 mM dithiothreitol (DTT) or 0.1 mM 5,5′-
dithiobis-2-nitrobenzoic acid (DTNB) for 5 min at room temperature.
Complex I activities were measured in the absence and presence of 5 mM
MgCl2 (a) or 2 mM n-ethylmaleimide (NEM) (b). In all cases, 1 mM
decylubiquinone (DBQ) was added to the samples before the reaction was
started by the addition of DBQ activity buffer containing 110 µM dNADH
and supplemented with either 5.5 mM MgCl2 or 2.2 mM NEM. The ﬁnal
concentrations of DBQ and membranes were 100 µM and 50 µg ml-1,
respectively. n-Decyl-quinazoline-amine (DQA)-sensitive dNADH:DBQ
oxidoreductase activities in Q133CPSST normalized to their respective
controls (parental) are indicated. Activities were measured at pH 8.5 since
the inhibition of the D-form by divalent cations is stronger at alkaline pH
values, as well as it favors the labeling of the exposed C40ND3 by NEM.
Data from three independent experiments (mean ± s.d.) are shown. *p <
0.05; ***p < 0.001; ****p < 0.0001, ANOVA with Bonferroni correction
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published structure of Y. lipolytica complex I in the deactive
form2. In the structure of the variant, the central part of the
TMH1-2ND3 loop is ordered (residues 38 to 46). The respective
connections to the helices TMH1 and THM2 lack electron den-
sity indicating that they are most likely ﬂexible and were thus
omitted from the structure. Residue C40 of loop TMH1-2ND3 and
residue Q133C of subunit PSST form a disulﬁde bond (Fig. 5,
Supplementary Fig. 7). This covalent link positions the tip of loop
TMH1-2ND3 close to strand β149-kDa. The tip protrudes into the
space between the 49-kDa, the PSST and the ND1 subunits.
Notably, the main chain of the TMH1-2ND3 loop is in a very
similar position compared to that in the structure of wild-type
complex I (Fig. 5). The side chain positions are not resolved in the
latter structure despite the slightly better resolution2. In addition,
the sulfur anomalous Fourier electron density map for wild-type
complex I lacks a peak at the position of C40 of loop TMH1-2ND3
(Supplementary Table 1). This indicates higher ﬂexibility of side
chain and loop, in line with the availability of the cysteine-thiol
for chemical modiﬁcation in the deactive form. Thus, the dis-
ulﬁde bond formation in Q133CPSST variant tethers the TMH1-
2ND3 loop in a position very similar to the one it assumes in the
deactive form of the wild-type complex.
Discussion
In summary, our results corroborate one of the central predictions
of the mechanistic hypothesis presented earlier2 that energy
transmission from the site of ubiquinone reduction to remotely
located proton pumps of complex I requires the movement of
TMH1-2ND3 as part of coordinated rearrangements of three loops
in subunits ND1, 49-kDa, and ND3. At the structural level, the
most plausible, although at this point speculative interpretation of
our ﬁndings would be as follows: Loop TMH1-2ND3 is required to
transmit the conformational changes induced through the reduc-
tion of ubiquinone in loop β1–β249-kDa to loop TMH5-6ND1. The
disulﬁde bridge in the mutant complex ﬁxes it in a position, which
prevents this transmission by keeping the loop from properly
interacting with the other loops, without interfering with the other
functionalities of the ubiquinone reactive site formed primarily by
domains of the 49-kDa and the PSST subunits. Unexpectedly,
ﬁxing loop TMH1-2ND3 at C40 seemed not to interfere with the A/
D transition, while any modiﬁcation of this residue by a thiol agent
locks complex I in the inactive D-form. This can be reconciled by
assuming that the modiﬁed but mobile loop can still engage with
loop β1–β249-kDa, but that the substituent blocks their functional
rearrangements at a critical point thereby preventing catalytic
turnover. Our results also seem to suggest that the differential
accessibility of loop TMH1-2ND3 has to be considered mainly as a
reporter for the A/D transition. The regulatory transitions of
complex I themselves rather seem to primarily involve loop β1–
β249-kDa and possibly some of the accessory subunits surrounding
it, as suggested by the recent structures of the active and deactive
form of mammalian complex I6.
More detailed data at high resolution ideally representing dif-
ferent reaction intermediates, modeling studies, and functional
data will be needed to decipher the conformational changes
associated with complex I turnover in detail. Being now able to
disconnect selectively and reversibly the proton pumping
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Fig. 3 Blocking movement of loop TMH1-2ND3 reversibly disengages the proton pumps. Proton pumping was monitored as 9-amino-6-chloro-2-
methoxyacridine (ACMA) ﬂuorescence quench in proteoliposomes containing either parental or mutant complex I treated with 5mM dithiothreitol (DTT)
(a, b) or 0.1 mM 5,5′-dithiobis-2-nitrobenzoic acid (DTNB) (c–f) for 5 min before starting the assay. As indicated, 0.5 µM ACMA, 70 µM decylubiquinone
(DBQ). 100 µM NADH and 5 µM carbonylcyanide m-chlorophenylhydrazine (CCCP) were added during the assay. Addition of 5 mM DTT to DTNB treated
proteoliposomes during the assay had no effect on parental complex I (e), but rapidly restored proton pumping of the mutant enzyme (f). Representative
traces of one out of four datasets obtained with independent batches of proteoliposomes are shown
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machinery from the redox chemistry of ubiquinone and its
control by the A/D transition in itself provides an invaluable tool
to elucidate the mechanism and regulation of mitochondrial
complex I.
Methods
Chemicals. All chemicals were purchased from Sigma-Aldrich® unless stated
otherwise.
Strains, growth conditions, and site-directed mutagenesis. All cloning proce-
dures were performed as described earlier25 and using enzymes and reagents from
New England BioLabs® Inc. unless stated otherwise. Brieﬂy, Q133CPSST was con-
structed by inverse PCR mutagenesis of pUB4/NUKM25 in Escherichia coli. The
desired point mutation was generated using appropriate primer pairs (Supple-
mentary Table 2). The forward primer (NUKM_Q133Cf) had a mismatch codon at
the 5’ end leading to the point mutation. The reverse primer (NUKM_Q133r)
ended just after the mismatch codon and contained no mismatch. Primers were
phosphorylated using the T4 polynucleotide kinase kit prior to PCR. The PCR
reaction mixture contained plasmid DNA harboring the NUKM gene as template
(~10 ng), both primers (0.5 μM each), dNTPs (120 μM), Phusion HF buffer and
Phusion DNA polymerase (2 units) in a ﬁnal volume of 50 μl. The reaction was
started by adding the Phusion DNA polymerase (manual hot start, 98 °C). PCR
products were incubated with DpnI overnight at 37 °C to get rid of the original
DNA template. Digested products were loaded onto a 1% agarose gel stained with
ethidium bromide and separated at 120 V for 1 h. Linear PCR products (~10.3 kb)
were cut under weak UV light and extracted from the gel spots using the
Nucleospin® Gel and PCR clean-up kit from Macherey & Nagel. DNA con-
centration was measured using a NanoDrop 1000 spectrophotometer (Thermo
Fisher Scientiﬁc). Cleaned products (100 ng DNA) were circularized by blunt-end
ligation using the Fast-LinkTM DNA ligation kit from Epicentre® following the
manufacturer’s instructions. Then, chemical-competent E. coli DH5α cells were
transformed with one third of the ligation reaction volume (5 µl) by heat shock
(30 s, 42 °C), incubated with SOC medium (0.5% yeast extract, 1% bacto-peptone,
1% NaCl, 10 mM MgCl2, 20 mM dextrose) for 1 h at 37 °C under vigorous shaking
and spread on selective LB (0.5% yeast extract, 1% bacto-peptone, 1% NaCl)+
100 µg ml−1 ampicillin agar plates overnight at 37 °C. The next day, ten resistant
clones were picked and grown individually in 3 ml LB+ 100 µg ml−1 ampicillin
liquid medium for 16 h at 37 °C with vigorous shaking. Plasmid DNA was isolated
using the QuickLyse Miniprep kit from QIAGEN® following the manufacturer’s
instructions. Puriﬁed plasmids were further digested with EcoRI and DNA frag-
ments were separated in an agarose gel as above described. Positive clones were
taken as the ones showing a two bands pattern at ~8 kb (empty pUB4 vector) and
~2.3 kb (NUKM gene). Before transformation into yeast cells, the entire NUKM
open reading frame and the correctness of the point mutation were veriﬁed by
DNA sequencing with primers NUKM-seq-1fw and NUKM-seq-2fw (Supple-
mentary Table 2).
Y. lipolytica strain nukmΔ (nukm::LEU2, nugm-Htg2, ndh2i, ura3−, lys11−)26
lacking the entire nuclear reading frame encoding subunit PSST was transformed
with replicative plasmid pUB4 containing either wild-type or site-directed mutant
copies of the NUKM gene under the control of its endogenous promoter.
Transformation of Y. lipolytica was performed according to the one-step protocol
described by Chen et al.27. Brieﬂy, 500 µl of an overnight YPD (1% yeast extract,
2% bacto-peptone, and 2% dextrose) culture of nukmΔ cells were spun down,
washed with deionized water and resuspended in 100 μl one-step buffer (45%(w/v)
PEG 4000, 0.1 M lithium acetate, 0.1 M DTT, 0.25 mgml−1 ssDNA). Then, 100 ng
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Fig. 4 The disulﬁde cross-link in mutant Q133CPSST does not change proton
permeability. Passive proton (H+) uptake was monitored as 9-amino-6-
chloro-2-methoxyacridine (ACMA) ﬂuorescence quench in proteoliposomes
containing either parental (black lines) or mutant (gray lines) complex I
treated with 5mM dithiothreitol (DTT) (a, b) or 0.1 mM 5,5′-dithiobis-2-
nitrobenzoic acid (DTNB) (c, d). In a, c 10mM HCl were added to establish a
transitory pH gradient. Proteoliposomes (5 µgml−1) were incubated for
5min at room temperature in a reaction mixture containing 20mMMops pH
7.2 (Tris), 80mM KCl and either 5mM DTT or 0.1 mM DTNB. 0.5 µM
ACMA and 0.5 µM valinomycin (VAL) were added immediately before
recording the baseline. In b, d a K+ gradient was used to drive complex I
independent H+ uptake. Proteoliposomes ([K+]i= 80mM) were incubated
in 20mM Mops pH 7.2 (Tris), 0.08mM KCl, 160mM sucrose and ΔΨ
generation was induced by the addition of 0.5 µM valinomycin (VAL). A slow
compensatory H+ uptake was observed. Finally, 0.05mgml−1 alamethicin
(ALA) was added to permeabilize the proteoliposomes and collapse the ion
gradients. For the bottom traces shown in all panels, 5 µM carbonylcyanide
m-chlorophenylhydrazine (CCCP) were added before the assay to dissipate
the proton gradient. Note that neither complex I substrates nor inhibitors
were used in these assays. Representative traces of one out of ﬁve technical
replicates are shown
TMH1
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Fig. 5 Formation of the disulﬁde cross-link immobilizes loop TMH1-2ND3
without displacing it. Section of the crystal structure of complex I from
mutant Q133CPSST showing the interface between membrane and
peripheral arms in cartoon representation. The ND3 loop connecting TMH1
and TMH2 (light green) protrudes into the cavity formed by subunits PSST
(blue), 49-kDa (blue-green), and ND1 (red). Residue C40ND3 forms a
disulﬁde bond with C133PSST (stick representation). This was conﬁrmed by
a strong peak in the sulfur anomalous difference Fourier electron density
map (yellow mesh) which was absent when analyzing wild-type complex I
crystals. Loop TMH1-2ND3 from the superimposed structure of wild-type
complex I [2] is shown in orange
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of plasmid DNA were added for each transformation mixture. The transformation
cocktail was thoroughly vortexed and incubated at 39 °C for 60 min. The mixture
was spread on a selective YPD+ 50 µg ml−1 Hygromycin B agar plate and
incubated for 48–72 h at 28 °C. Five resistant clones were singularized and grown
individually in bafﬂed ﬂasks containing 30 ml YPD+ 50 µg ml−1 Hygromycin B
liquid medium for 24 h at 28 °C with vigorous shaking. The next day, pre-cultures
were transferred into bafﬂed ﬂasks containing 450 ml YPD+ 50 µg ml−1
Hygromycin B liquid medium and the growth continued for 16 h under the same
conditions. Yeast cells were harvested and used for mitochondrial membranes
isolation. The Q133CPSST mutation was veriﬁed at the protein level by MS
following separation by Blue Native-PAGE and in-gel digestion of the complex I
band with trypsin. Haploid strain nukmΔ26 complemented with pUB4 carrying the
wild-type NUKM gene or (for experiments with puriﬁed complex I) haploid strain
GB20 (mus51Δ, nugm-Htg2, ndh2i, lys11−, leu2−, ura3−, MatB) were used as
controls and denoted parental throughout.
For crystallization of complex I we deleted the gene encoding subunit ST1
known to be present sub-stoichiometrically in the puriﬁed enzyme28 from Y.
lipolytica strain GB20 following the gene deletion and marker rescue strategy of
Fickers et al.29. Speciﬁcally, for cloning of the ﬂanking regions of the ST1 gene and
introducing the Sce I sites for insertion of the loxR-URA3-loxP disruption cassette
we used primer pairs ST1_P1/ST1_P2 and ST1_T1/ST1_T2, respectively
(Supplementary Table 2). The NUKM gene was deleted from the haploid st1Δ
strain (mus51Δ, st1Δ, nugm-Htg2, ndh2i, lys11−, leu2−, ura3−; denoted wild type
in this study) by homologous recombination following the strategy described in
Ahlers et al.30 to obtain the double deletion strain nukmΔst1Δ (mus51Δ, nukm::
LEU2, st1Δ, nugm-Htg2, ndh2i, ura3−, lys11−). Brieﬂy, genomic DNA from strain
nukmΔ was isolated and used as template to amplify the nukm::LEU2 allele
(~2.5 kb) by PCR using primers nukmleu2_fw2 and nukmleu2_rv2
(Supplementary Table 2). The correct PCR product was extracted from the gel and
cleaned as above described. Then, 500 µl overnight YPD culture of st1Δ cells were
spun down, washed with deionized water, and resuspended in 100 μl one-step
buffer. Yeast cells were further transformed with 100–200 ng of linear DNA and
spread on SD (2% dextrose, 0.67% YNB w/o aminoacids, 50 mM phosphate buffer,
pH 6.0) agar plates supplemented with 0.03 mgml−1 L-lysine and 0.02 mgml−1
uridine and incubated for 72–96 h at 28 °C. Fifteen LEU2 clones were screened for
the correct homologous recombination at the NUKM gene locus by PCR using
primers nukm5UTR_fw and leu2inv_rv (Supplementary Table 2) and using
genomic DNA as template. Moreover, mitochondrial membranes from four
putative nukmΔst1Δ clones were isolated in order to conﬁrm the absence of
assembled complex I by BN PAGE and activity measurements (see below). The
correct double deletion strain was ﬁnally complemented with shuttle vector pUB4
carrying the mutated NUKM gene (Q133CPSST).
Preparation of mitochondrial membranes. Small-scale isolation of unsealed
mitochondrial membranes from parental and mutant strains was carried out
essentially as described in Kerscher et al.31 with minor modiﬁcations. Brieﬂy,
freshly harvested cells (~10 g wet weight) were resuspended in mitobuffer (600 mM
sucrose, 20 mMK+-Mops pH 7.2, 1 mM EDTA, 2 mM phenylmethylsulfonyl
ﬂuoride (PMSF)) and broken by vortexing (10 × 1 min with 1 min resting intervals
on ice) in the presence of 10 g glass beads (0.45 mm). Glass beads, unbroken cells
and nuclei were removed by centrifugation at 3300 × g (45 min, 4 °C). From
supernatants, mitochondrial membranes were sedimented by centrifugation at
40,000 × g (120 min, 4 °C). Finally, the pellets were resuspended in 500 µl mito-
buffer, homogenized and shock frozen as aliquots in liquid nitrogen and stored at
−80 °C. Aliquots were thawed on ice before use. Protein concentration was
determined using the DC protein assay kit (Bio-Rad).
For puriﬁcation of complex I, Y. lipolytica cells were grown overnight at 28 °C
in a 10 l fermenter (Biostat C, Sartorius) in YPD. After 16–20 h, cells were
harvested by centrifugation for 10 min at 5000 × g and 4 °C. For large-scale
mitochondrial membranes preparation, cells (200 g wet weight) were resuspended
in 400 ml buffer A (600 mM sucrose, 1 mM EDTA, 20 mM Na+/Mops, pH 7.2) in
the presence of 1.5 mM PMSF. Cells were broken using a cooled Cell-
Desintegrator-C, (Bernd Euler Biotechnologie) and 80 ml of 0.5 mm glass beads for
2 h. Cells debris was sedimented by centrifugation (30 min, 4400 × g, 4 °C) and
mitochondrial membranes were obtained by ultracentrifugation (90 min,
167,000 × g, 4 °C). The pellet was resuspended in buffer A without EDTA and
centrifuged again (60 min, 174,000 × g, 4 °C). Sedimented membranes were
homogenized in buffer B (600 mM sucrose, 50 mM NaCl, 20 mM Na-Borate,
20 mM Na+/Mops, pH 7.2, supplemented with 1.5 mM PMSF immediately prior to
use), shock frozen in liquid nitrogen and stored at −80 °C.
Puriﬁcation of complex I. Puriﬁcation of n-dodecyl-β-D-maltoside (DDM)
solubilized complex I from control and mutant strains was performed by Ni-
afﬁnity chromatography and gel ﬁltration as described32 with some modiﬁca-
tions33. Brieﬂy, mitochondrial membranes were thawed and adjusted to a con-
centration of 18 mgml−1 protein with 50 mM NaCl, 20 mM Na-Borate; pH 7.2,
1.5 mM PMSF. A total of 3400–4000 mg mitochondrial protein was typically used.
DDM was added dropwise from a 20% (w/v) stock solution to a ﬁnal detergent to
protein ratio of 1 g:1 g. The solution was stirred on ice for 10 min and then cen-
trifuged at 147,000 × g for 1 h. The supernatant was adjusted to 400 mM NaCl,
55 mM imidazole, 0.8 mM MgCl2 and pH 7.3–7.4 prior to loading onto a 50 ml Ni-
NTA Sepharose column (Bio-Rad) equilibrated with 55 mM imidazole, 400 mM
NaCl, 0.025% DDM, and 20 mM Na-phosphate, pH 7.2. The column was washed
with 150 ml of the same buffer and complex I was eluted with 200 ml of 140 mM
imidazole, 400 mM NaCl, 0.025% DDM, and 20 mM Na-phosphate, pH 7.2.
Complex I content of fractions was evaluated by measuring the electron transfer
activity from NADH to the non-physiological electron acceptor hexaamminer-
uthenium(III)-chloride (HAR). NADH oxidation (ε 340–400 nm= 6.22 mM−1 cm−1)
was measured in a reaction mix containing 20 mM Na/Hepes, pH 8.0, 250 mM
sucrose, 2 mM NaN3, 0.2 mM EDTA, 0.2 mM NADH, and 2 mM HAR in a Shi-
madzu UV-2450 sprectrophotometer. Peak fractions were combined and con-
centrated using Centriped centrifugal ﬁlter devices (Millipore®). For size exclusion
chromatography, the concentrated pool was applied to a TSK gel G4000SW col-
umn (TosoH Bioscience). For equilibration and elution was performed with
100 mM NaCl, 1 mM EDTA, 20 mM Tris/HCl, pH 7.2 and 0.025% DDM. Chro-
matography was performed on an Äkta puriﬁer chromatography system (GE
Healthcare). Peak fractions were pooled, concentrated using spin devices, (Vivas-
pin, 100.000 MWCO, Sartorius) and aliquots were shock frozen and stored in
liquid nitrogen.
For protein crystallization, complex I was puriﬁed essentially as described above
but with some modiﬁcations34. During His-tag afﬁnity chromatography the
detergent was changed from 0.025% DDM to 0.015% of the polyoxyethylene
detergent C12E9 (Thesit) and the column was washed with only 115 ml of the buffer
containing Thesit instead of DDM.
Gel electrophoresis. For Blue-native (BN) PAGE, mitochondrial membranes
(200 µg protein per lane) were solubilized with 2 g DDM per g protein in 50 mM
imidazole-HCl pH 7.0, 500 mM 6-aminohexanoic acid, 1 mM EDTA, and cen-
trifuged at 22,000 × g for 20 min at 4 °C. Supernatants were supplemented with
Coomassie brilliant blue G-250 (Serva G) and protein complexes were separated in
4–16% acrylamide gradient gels as detailed in Wittig et al.35 for about 3 h at 30 mA,
400 V, 10W in a cold room (4–6 °C). Complex I in-gel staining was done according
to Nübel et al.36 by incubating the gel in 25 mM Tris/HCl, pH 7.4 supplemented
with 2.5 mg ml−1 nitrotetrazolium blue (NTB) and 1 mM NADH. After 30 min,
the reaction was stopped by incubating the gel in 50% methanol, 10% acetic acid.
Gels were further washed and maintained in deionized water indeﬁnitely.
Where indicated, puriﬁed complex I (30 µg per lane) was diluted to 50 µl with
20 mMK+-Mops pH 7.2, 80 mM KCl and treated with either 5 mM DTT or
0.1 mM 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) for 5 min at room
temperature prior to the addition of 20 µl of non-reducing sample buffer B (12%
(w/v) SDS, 30% (w/v) glycerol, 0.05% Coomassie blue G-250, 150 mM Tris-HCl pH
7.0)37. In order to analyze the subunit composition of complex I, protein samples
were loaded onto a 16% polyacrylamide Tricine-SDS-gel and separated under non-
reducing conditions overnight at 120 V, room temperature. The gels were
Coomassie-stained according to Schägger37. In short, gels were ﬁxed in 50%
methanol, 10% acetic acid, 100 mM ammonium acetate for 1 h, stained with
0.025% Coomassie dye in 10% acetic acid for 2 h, destained twice in 10% acetic acid
(1 h each) and kept in deionized water for further usage.
For 2D Tricine-SDS-PAGE (dSDS-PAGE), the ﬁrst dimension was performed
under non-reducing conditions using 10% polyacrylamide gels. For the second-
dimension, whole complex I lanes were excised, Coomassie-stained and incubated
in 50 mM Tris-HCl pH 8.0, 1%(w/v) SDS, 1%(v/v) 2-mercaptoethanol for 30 min
at room temperature to reduce disulﬁde bonds. Then the gel strips were placed on
top of 16% polyacrylamide gels and the proteins were now separated under
reducing conditions. After electrophoresis gels were silver-stained according to
Schägger37. Brieﬂy, gels were ﬁxed as above described, washed twice with deionized
water (1 h each), sensitized with 0.005% sodium thiosulfate for 1 h, incubated with
0.1% silver nitrate for 1 h, washed with deionized water for a few seconds and
incubated with 0.036% formaldehyde, 2% sodium carbonate until the protein
bands/spots were visible (1–2 min). In order to stop the staining, gels were
incubated in 50 mM EDTA disodium salt, pH 4.6 for 5 min and later washed and
maintained in deonized water indeﬁnitely.
Mass spectrometry. Proteins were identiﬁed by MS after tryptic in-gel digestion
essentially following the protocol described in Heide et al.38 with slight mod-
iﬁcations. In short, protein-containing gel slices were cut out and diced in smaller
pieces before they were transferred to a 96-well ﬁlter ﬂate (Millipore®,
MABVN1250) adapted manually to a 96-well plate (MaxiSorpTM Nunc) as waste
collector. Gel pieces were incubated several times with 50% methanol, 50 mM
ammonium hydrogen carbonate (AHC) under gentle agitation until they were
destained completely. Excess solution was removed by centrifugation (2500 × g,
20 s). In the next step, gel pieces were incubated with 120 µl of 10 mM DTT for
60 min. After removal of excess solution (2500 × g, 20 s), 120 µl of 30 mM chlor-
oacetamide was added to each well and removed after 45 min. After a washing step
with 50% methanol, 50 mM AHC, gel pieces were dried at room temperature for
45 min. The dried gel pieces were swollen by adding 20 µl of 5 ng µl−1 trypsin
(sequencing grade, Promega®), 50 mM AHC, 1 mM CaCl2 per well for 30 min at
4 °C. Then, 50 µl of 50 mM AHC was added to cover the gel pieces, followed by an
overnight incubation at 37 °C to digest the proteins. The peptide-containing
supernatants were collected by centrifugation (2500 × g, 30 s) into a 96-well PCR
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plate (Axygen®). The gel pieces in the ﬁlter plate were washed once with 50 µl of
30% acetonitrile, 3% formic acid for 20 min to elute the remaining peptides. The
combined eluates were dried in a SpeedVac Concentrator Plus (Eppendorf). Prior
to MS, peptides were resuspended in 20 µl of 5% acetonitrile, 0.5% formic acid.
Tryptic peptides were separated by reverse-phase liquid chromatography and
analyzed by tandem MS in a Q-Exactive Orbitrap Mass Spectrometer equipped
with an Easy nLC1000 nano-ﬂow ultra-high-pressure liquid chromatography
system (Thermo Fisher Scientiﬁc). Peptides were separated using a 100 µm ID ×
15 cm length PicoTipTM EMITTER column (new objective) ﬁlled with ReproSil-
Pur C18-AQ reverse-phase beads of 3 µm particle size and 120 A˚ pore size (Dr.
Maisch GmbH, Germany) using linear gradients of 5–35% acetonitrile, 0.1% formic
acid (30 min) at a ﬂow rate of 300 nl min−1, followed by 35–80% acetonitrile, 0.1%
formic acid (5 min) at 600 nl min−1 and a ﬁnal column wash with 80% acetonitrile
(5 min) at 600 nl min−1. The mass spectrometer operated in positive ion mode
switching automatically between MS and data-dependent MS2 of the top 20 most
abundant precursor ions. Full-scan MS mode (400–1400m/z) was set at a
resolution of 70,000m/Δm with an automatic gain control target of 1 × 106 ions
and a maximum injection time of 20 ms. Selected ions for MS/MS were analyzed
using the following parameters: resolution 17,500m/Δm, automatic gain control
target 1 × 105; maximum injection time 50 ms; precursor isolation window 4.0 Th.
Only precursor ions of charge z= 2 and z= 3 were selected for collision-induced
dissociation. Normalized collision energy was set to 30% at a dynamic exclusion
window of 60 s. A lock mass ion (m/z= 445.12) was used for internal calibration39.
MS raw data ﬁles were analyzed using the MaxQuant software (v1.5.0.25)
applying the settings detailed in Huynen et al.,40 except that searching was done
against an in-house compiled version of the Y. lipolytica protein database from
NCBI including annotations of all known complex I subunits as well as the
sequences of the pig trypsin and known contaminants, such as human keratins. In
addition to the original sequence of subunit NUKM/PSST, an entry for this protein,
in which the original glutamine 133 was changed to cysteine, was added manually.
The limit for the false discovery rate determined by target-decoy database search
was set to 0.01. Database searches were done with 20 ppm and 0.5 Da mass
tolerances for precursor ions and fragmented ions, respectively. Trypsin (two
missed cleavages allowed) was selected as the protease. Dynamic modiﬁcations
included N-terminal acetylation and oxidation of methionine. Cystein
carbamidomethylation was set as a ﬁxed modiﬁcation. Intensity-Based Absolute
Quantiﬁcation of proteins (iBAQ)-values were normalized between samples by
dividing them by the sum of iBAQ-values from complex I subunits 51-kDa, 49-kDa
and ND5, which were used as loading controls.
Activity measurements. Complex I activities were determined by measuring the
initial oxidation rates of deamino-NADH (dNADH) using a SPECTRAmax
PLUS384 plate reader spectrophotometer (Molecular Devices) at 360 nm (ε360nm
= 4.46 mM−1 cm−1). This wavelength was chosen as isosbestic point of the
DTNB/ 2-nitro-5-thiobenzoate (TNB) redox spectra to avoid optical inference
from these compounds. dNADH was used in assays with mitochondrial mem-
branes since it is a speciﬁc substrate for complex I and cannot be oxidized by
alternative NADH dehydrogenases41. Mitochondrial membranes were diluted to
0.5 mg protein ml−1 in pre-incubation buffer (50 mM Tris-HCl pH 7.2, 80 mM
KCl, 0.2 mM EDTA) and kept on ice. To measure dNADH:hexaamminer-
uthenium(III)-chloride (HAR) oxidoreductase activity, aliquots of 12.5 µl
membranes were added into 12.5 µl pre-incubation buffer supplemented with
5 mM DTT or 0.1 mM DTNB and incubated in the multi-well plate (Max-
iSorpTM Nunc) for 5 min at room temperature. The reaction was started by the
addition of 225 µl HAR activity buffer (50 mM Tris-HCl pH 8.5, 80 mM KCl,
0.2 mM EDTA, 1.1 mM NaCN, 220 µM dNADH, and 2.2 mM HAR) and
monitored for 3 min at 25 °C. Both dNADH and HAR were added to the assay
buffer immediately before starting the reaction. The ﬁnal concentration of
membranes was 25 µg protein ml−1. To measure dNADH:decylubiquinone
(DBQ) oxidoreductase activity, aliquots of 25 µl membranes were incubated with
either 5 mM DTT or 0.1 mM DTNB for 5 min at room temperature. Note that
irreversible and complete inactivation of parental complex I was observed after
prolonged incubation (>30 min) with DTNB, since the reagent slowly reacted
with free cysteine-thiols. One minute before ﬁnishing the incubations, 1 mM
decylubiquinone was added to the samples. Then, the reaction was started by the
addition of 225 µl DBQ activity buffer (50 mM Tris-HCl pH 8.5, 80 mM KCl,
0.2 mM EDTA, 1.1 mM NaCN, and 110 µM dNADH) and monitored for 3 min
at 25 °C. The ﬁnal protein concentration of membranes was 50 µg protein ml−1.
In both HAR and DBQ activity assays, the ﬁnal volume of the reaction was
250 µl; path length: 0.6 cm. Inhibitor-sensitive dNADH:DBQ activities were
calculated by subtracting the residual rate in the presence of 10 μM 2-n-decyl-
quinazolin-4-yl-amine (DQA). To allow comparison between different pre-
parations, all activities were normalized to their respective dNADH:HAR
activities. IC50 values and kinetic parameters (apparent Km and Vmax) were
determined as described26. For determination of kinetic parameters, data were
ﬁtted to the standard Michaelis-Menten equation using GraphPad Prism (v6.01).
IC50 was deﬁned as the concentration of inhibitor required to decrease the
inhibitor-sensitive complex I activity by 50%. Activities in the absence of either
DQA or rotenone corrected for residual unspeciﬁc dNADH:DBQ oxidoreductase
activity in strain nukmΔ were taken as 100%.
EPR spectroscopy. Low temperature cw-EPR spectra were obtained using a
Bruker ESP 300E spectrometer equipped with a liquid helium continuous ﬂow
cryostat, ESR 900 (Oxford Instruments). Samples of puriﬁed complex I were
diluted to 5 mg protein ml−1 in 20 mM Hepes pH 7.5, 100 mM NaCl, incubated
with either 5 mM DTT or 0.1 mM DTNB for 5 min on ice and then mixed with
2 mM NADH in the EPR tube and frozen in liquid nitrogen after 30 s reaction
time. Spectra were recorded as described earlier26 using instrument settings as
listed in the ﬁgure legend.
Proton pumping and activity of reconstituted complex I. Puriﬁed complex I
(200 µg) from either GB20 or mutant strain Q133CPSST was reconstituted into
proteoliposomes at a protein-to-lipid ratio of 1:50 (w/w) following the protocol
described in Dröse et al.22,42 with one important modiﬁcation. During detergent
removal, the four incubations with BioBeads (Bio-Rad) were shortened to 30 min
each. Prior to reconstitution of the enzyme, 10 mgml−1 asolectin from soybean
were solubilized in 1.6% Octyl β-D-glucopyranoside, 20 mMK+-Mops pH 7.2,
80 mM KCl. After detergent removal, proteoliposomes were collected by cen-
trifugation at 100,000 × g (1 h, 4 °C) and dissolved carefully in 200 µl of 20 mMK
+-Mops pH 7.2, 80 mM KCl. Typically, proteoliposomes were prepared in parallel
and analyzed on the same day. After reconstitution, protein concentration was
determined using the DC protein assay kit (Bio-Rad) and the orientation of
complex I in the membrane was evaluated by measuring NADH:HAR oxidor-
eductase activities before and after adding 0.05% (w/v) DDM to make the mem-
branes permeable for the substrates. The fraction of peripheral arm facing outside
was found to be consistently 65 ± 5% for both parental and mutant complex I.
Proton pumping was monitored by ACMA ﬂuorescence quenching essentially as
described in Dröse et al.22 except that the protocol was adapted to ﬂuorescence
measurement in 96-well black microplates (Flat bottom, non binding, Nunc).
Fluorescence changes were monitored at 25 °C in a Spectramax M2e plate reader
(Molecular Devices). Settings: λex= 430 nm, λem= 475 nm, top read mode, auto
cutoff, PMT medium. Proteoliposomes (5 µg protein) were diluted in 100 µl of
assay buffer (20 mMK+-Mops pH 7.2, 80 mM KCl, 0.5 µM valinomycin) and
treated with either 5 mM DTT or 0.1 mM DTNB for 5 min at room temperature.
Then, 20 µl aliquots from each sample were diluted to 200 µl with assay buffer
yielding a ﬁnal concentration of proteoliposomes 5 µg protein ml−1. After starting
the measurement 0.5 µM ACMA, 70 µM DBQ, 100 µM NADH, and 5 µM carbonyl
cyanide m-chlorophenyl hydrazine (CCCP) were added subsequently after 60, 120,
180 and 360 s, respectively. NADH:DBQ oxidoreductase activities of the recon-
stituted enzyme in the presence and absence of 5 µM CCCP were determined at a
ﬁnal concentration of 5 µg protein ml−1. The same protocol as for mitochondrial
membranes was used, except that samples were diluted in 20 mMK+-Mops pH 7.2,
80 mM KCl and that 100 µM NADH and 70 µM DBQ were added as substrates.
Crystallography. Crystals of complex I from wild-type and mutant Q133CPSST
were grown essentially as described before2. Brieﬂy, puriﬁed complex I from wild
type and mutant was crystallized using the hanging-drop vapor diffusion method
in 24-well plates (Crystalgen) at a protein concentration of 35 mg/ml at 19.5 °C;
0.2% Cymal 4 (Anatrace) and 1 mM NADPH were used as additives. Up to
1.75 mM phosphatidylcholine was added to the protein solution to achieve growth
of large (>300 µm) single crystals. The protein solution was mixed in a 1:1 ratio
with 7% PEG 3350, 12% glycerol, 40 mM Ca-acetate, pH 7.3. After 15 min at room
temperature the sample was centrifuged at 16,000 × g for 5 min at 18 °C and the
clear supernatant was pipetted on siliconized cover slides (Jena Bioscience) and
placed over a series of well solutions containing 6% PEG 3350, 40 mM calcium-
acetate, 12% glycerol with incremental changes from pH 6.2 to pH 7. After about
one week, crystals were cryo-protected by transfer into 20% PEG 3350, 40 mM
calcium-acetate, 30% glycerol pH 6.3 and frozen in liquid propane.
X-ray diffraction data were collected at 12.398 keV on beamline PXI (Swiss
Light Source, Paul Scherrer Institut, Villigen, Switzerland). The beamline is
equipped with an Eiger 16 M detector. In order to locate precisely the sulfur atoms
in an anomalous Fourier electron density map, highly redundant data were
collected using X-rays at 5.975 keV and 5.2 keV on beamline P13 operated by
EMBL Hamburg at the PETRA III storage ring (DESY, Hamburg, Germany) using
measurement conditions close to those used for native-SAD data collection43. All
diffraction experiments were performed at 100 K.
Diffraction data were processed with XDS or Autoproc44,45 and scaled with
XSCALE or with Aimless46. Similarly to the wild-type structure2, the diffraction
data are strongly anisotropic and anisotropically truncated using STARANISO47
and the anisotropy correction server48. The previously determined complex I
structure from Y. lipolytica (PDB code: 4wz7)2 was used as start model for the
reﬁnement of the Q133CPSST variant structure. The model was improved using
iterative cycles of manual rebuilding with COOT49 and reﬁnement with
BUSTER50, resulting in a structure at the anisotropic resolution of 4.2 × 4.2 × 3.8 Å.
In the ﬁnal structure, the 14 central subunits mostly include side chains while
accessory subunits were modelled as poly-alanine due to limited resolution. The
structure was reﬁned to ﬁnal Rwork and Rfree values of 36.1% and 36.3% respectively
with 87.03% and 9.82% of the residues in the most favored and allowed areas of the
Ramachandran plot, while only 3.15% are in disallowed regions.
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Statistical analysis. If not indicated otherwise, data were analyzed by two-way
ANOVA with Bonferroni correction. Results are presented as mean value ± stan-
dard deviation. Statistical signiﬁcance is indicated as follows: *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001.
Data availability
The X-ray structure of complex I from Yarrowia lipolytica mutant Q133CPSST as
well as the structure factors have been deposited in the Protein Data Bank with
accession code 6H8K [http://www.rcsb.org/structure/6H8K]. All other data sup-
porting the ﬁndings of the current study are available from the corresponding
author on reasonable request.
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